XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.20.2

GOODWILL AND OTHER INTANGIBLE ASSETS (Notes) | 9 Months Ended
--- | ---
Jul. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND OTHER INTANGIBLE ASSETS | GOODWILL AND OTHER INTANGIBLE ASSETS The following table presents goodwill balances and the movements for each of our reportable segments during the nine months ended July 31, 2020:
| Life Sciences and Applied Markets |  | Diagnostics and Genomics |  | Agilent CrossLab |  | Total
| (in millions)
Goodwill as of October 31, 2019 | $ | 1,438 |  |  | $ | 1,594 |  |  | $ | 561 |  |  | $ | 3,593 |
Foreign currency translation impact | 5 |  |  | 6 |  |  | 2 |  |  | 13 |
Goodwill as of July 31, 2020 | $ | 1,443 |  |  | $ | 1,600 |  |  | $ | 563 |  |  | $ | 3,606 |
The components of other intangible assets as of July 31, 2020 and October 31, 2019 are shown in the table below:
| Purchased Other Intangible Assets
| Gross Carrying Amount |  | Accumulated Amortization |  | Net Book Value
| (in millions)
As of October 31, 2019 |  |  |  |  |  |  |  |
Purchased technology | $ | 1,413 |  |  | $ | 763 |  |  | $ | 650 |
Backlog | 5 |  |  | 5 |  |  | — |
Trademark/Tradename | 196 |  |  | 102 |  |  | 94 |
Customer relationships | 329 |  |  | 87 |  |  | 242 |
Third-party technology and licenses | 28 |  |  | 22 |  |  | 6 |
Total amortizable intangible assets | 1,971 |  |  | 979 |  |  | 992 |
In-Process R&D | 115 |  |  | — |  |  | 115 |
Total | $ | 2,086 |  |  | $ | 979 |  |  | $ | 1,107 |
As of July 31, 2020 |  |  |  |  |  |  |  |
Purchased technology | $ | 1,419 |  |  | $ | 839 |  |  | $ | 580 |
Trademark/Tradename | 196 |  |  | 113 |  |  | 83 |
Customer relationships | 330 |  |  | 142 |  |  | 188 |
Third-party technology and licenses | 28 |  |  | 24 |  |  | 4 |
Total amortizable intangible assets | 1,973 |  |  | 1,118 |  |  | 855 |
In-Process R&D | 21 |  |  | — |  |  | 21 |
Total | $ | 1,994 |  |  | $ | 1,118 |  |  | $ | 876 |
During the nine months ended July 31, 2020, there were no additions to goodwill and there were no additions to other intangible assets. During the nine months ended July 31, 2020, other intangible assets decreased $1 million due to the impact of foreign currency translation. In general, for United States federal tax purposes, goodwill from asset purchases is deductible; however, any goodwill created as part of a stock acquisition is not deductible. Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible assets and goodwill is indicated. During the three and nine months ended July 31, 2020, we did not identify any triggering events or circumstances, including events due to COVID-19, which would indicate an impairment of goodwill. During the nine months ended July 31, 2020, we recorded an impairment of in-process research and development of $90 million related to the shut-down of our sequencer development program in our diagnostics and genomics segment. There were no indicators of impairments of indefinite-lived intangible assets or goodwill during the three and nine months ended July 31, 2019, respectively. Amortization expense of intangible assets was $45 million and $140 million for the three and nine months ended July 31, 2020, respectively. Amortization expense of intangible assets was $27 million and $82 million for the three and nine months ended July 31, 2019, respectively. Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2020 and for each of the five succeeding fiscal years and thereafter is estimated below:
Estimated future amortization expense: |
(in millions) |
Remainder of 2020 | $ | 45 |
2021 | $ | 172 |
2022 | $ | 150 |
2023 | $ | 107 |
2024 | $ | 86 |
2025 | $ | 68 |
Thereafter | $ | 227 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration